Rapid degradation of gliadin peptides toxic for coeliac disease patients by proteases from germinating cereals

Journal of Cereal Science

Volumn 44, Issue 3, 2006, Pages 368-371

  Hartmann, Georg ^a   Koehler, Peter ^a   Wieser, Herbert ^a  

^a DEUTSCHE FORSCHUNGSANSTALT FÜR LEBENSMITTELCHEMIE   (Germany)

Author keywords

Cereals; Coeliac disease; Germination; Proteases

Indexed keywords

BACTERIA (MICROORGANISMS); HORDEUM VULGARE SUBSP. VULGARE; SECALE CEREALE; TRITICUM AESTIVUM;

EID: 33750618989     PISSN: 07335210     EISSN: 10959963     Source Type: Journal    
DOI: 10.1016/j.jcs.2006.10.002     Document Type: Article

References (21)

1. Arentz-Hansen E.H., McAdam S.N., Molberg O., Kristiansen C., and Sollid L.M. Production of a panel of recombinant gliadins for the characterisation of T cell activity in coeliac disease. Gut 46 (2000) 46-51
2. Arentz-Hansen H., Korner R., Molberg O., Quarsten H., Vader W., Kooy Y.M.C., Lundin K.E.A., Koning F., Roepstorff P., Sollid L.M., and McAdam S.N. The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. Journal of Experimental Medicine 191 (2000) 603-612
3. Bethune M.T., Strop P., Tang Y., Sollid L.M., and Khosla C. Heterologous expression, purification, refolding, and structural-functional characterization of EP-B2, a self-activating barley cysteine endoprotease. Chemistry and Biology 13 (2006) 637-647
4. Broenstad, G.O., Reichelt, K.L., Slinde, E., 2003. A composition for lowering the concentration of intestinal pathogenic peptides. Patent No. WO03028745.
5. De Ritis G., Auricchio S., Jones H.W., Lew E.J.L., Bernardin J.E., and Kasarda D.D. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. Gastroenterology 94 (1988) 41-49
6. Des Varannes S.B., Gharib H., Bicheler V., Bost R., Bonaz B., Stanescu L., Delchier J.C., and Bonnot-Marlier S. Effect of low-dose rabeprazole and omeprazole on gastric acidity: results of a double blind, randomized, placebo-controlled, three-way crossover study in healthy subjects. Alimentary Pharmacology and Therapeutics 20 (2004) 899-907
7. Edens L., Dekker P., Van der Hoeven R., Deen F., de Roos A., and Floris R. Extracellular prolyl endoprotease from aspergillus niger and its use in the debittering of protein hydrolysates. Journal of Agricultural and Food Chemistry 53 (2005) 7950-7957
8. Ellis H.J., Pollock E.L., Engel W., Fraser J.S., Rosen-Bronson S., Wieser H., and Ciclitira P.J. Investigation of the putative immunodominant T cell epitopes in coeliac disease. Gut 52 (2003) 212-217
9. Fraser J.S., Engel W., Ellis H.J., Moodie S.J., Pollock E.L., Wieser H., and Ciclitira P.J. Coeliac disease: in vivo toxicity of the putative immunodominant epitope. Gut 52 (2003) 1698-1702
10. Jones B.L. Endoproteases of barley and malt. Journal of Cereal Science 42 (2005) 139-156
11. Kasarda D.D., Okita T.W., Bernardin J.E., Baecker P.A., Nimmo C.C., Lew E.J.L., Dietler M.D., and Greene F.C. Nucleic acid (cDNA) and amino acid sequences of α-type gliadins from wheat (Tricitcum aestivum). Proceedings of the National Academy of Sciences of the United States of America 81 (1984) 4712-4716
12. Matysiak-Budnik T., Candalh C., Cellier C., Dugave C., Namane A., Vidal-Martinez T., Cerf-Bensussan N., and Heyman M. Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease. Gastroenterology 129 (2005) 786-796
13. Shan L., Molberg ∅., Parrot I., Hausch F., Filiz F., Gray G.M., Sollid L.M., and Khosla C. Structural basis for gluten intolerance in celiac sprue. Science 297 (2002) 2275-2279
14. Shidrawi R.G., Day P., Przemioslo R., Ellis H.J., Nelufer J.M., and Ciclitira P.J. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture. Scandinavian Journal of Gastroenterology 30 (1995) 758-763
15. Siegel M., Bethune M.T., Gass J., Ehren J., Xia J., Johannsen A., Stuge T.B., Gray G.M., Lee P.P., and Khosla C. Rational design of combination enzyme therapy for celiac sprue. Chemistry and Biology 13 (2006) 649-658
16. Sollid L.M. Coeliac disease: dissecting a complex inflammatory disorder. Nature Reviews Immunology 2 (2002) 647-655
17. Sollid L.M., and Khosla C. Future therapeutic options for celiac disease. Nature Clinical Practice 2 (2005) 140-147
18. Stepniak D., Spaenij-Dekking L., Mitea C., Moester M., de Ru A., Baak-Pablo R., van Veelen P., Edens L., and Koning F. Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease. American Journal of Physiology. Gastrointestinal and Liver Physiology 291 (2006) G621-G629
19. Sturgess R., Day P., Ellis H.J., Lundin K.E.A., Gjertsen H.A., Kontakou M., and Ciclitira P.J. Wheat peptide challenge in coeliac disease. The Lancet 343 (1994) 758-761
20. Wieser H., Belitz H.D., and Ashkenazi A. Amino-acid sequence of the coeliac active gliadin peptide B 3142. Zeitschrift fuer Lebensmittel-Untersuchung und -Forschung 179 (1984) 371-376
21. Wieser H., Antes S., and Seilmeier W. Quantitative determination of gluten protein types in wheat flour by reversed-phase high-performance liquid chromatography. Cereal Chemistry 75 (1998) 644-650